{"id":"W2899764361","doi":"10.1016/s0140-6736(18)32590-x","title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","year":2018,"lang":"en","type":"review","venue":"The Lancet","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2818,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Heart failure; Hazard ratio; Meta-analysis; Diabetes mellitus; Stroke (engine); Myocardial infarction; Adverse effect; Renal function; Disease; Cardiology; Placebo; Type 2 diabetes; Proportional hazards model; Clinical trial; Intensive care medicine; Confidence interval; Endocrinology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}